- Wednesday, 30 September 2015 17:18
“The fetal cells are vital at this time because, to our knowledge, they have the best properties for the kinds of experiments that we need to do.”
Larry Goldstein University of California, San Diego
Larry Goldstein is trying to find drugs to treat Alzheimer’s disease. A biologist in cellular and molecular medicine at the University of California, San Diego, Goldstein also just started testing something he hopes will enable paralyzed people to walk again.
For both lines of research, he’s using cells from aborted fetuses.
“The fetal cells are vital at this time because, to our knowledge, they have the best properties for the kinds of experiments that we need to do,” Goldstein says.
Research involving fetal tissue has come under renewed public scrutiny recently because of a series of videos involving the Planned Parenthood Federation of America. The president of the organization, Cecile Richards, is slated to testify before a House committee Tuesday, even as some members of Congress try to cut off funding for Planned Parenthood, and some states try to restrict research involving fetal tissue.
READ MORE / LISTEN: NPR
- Saturday, 26 September 2015 23:51
Among the stem cell population, fetal stem cells (FSCs)
have also been used in neurological diseases. These cells
are more specialized compared to embryonic stem cells,
but at the same time have high proliferative potential and
are effectively being used in a number of diseases, including
neurological ones, without the need for human leukocyte
antigen (HLA) matching.
Dove Press Journal of Neurorestoratology
Abstract:The absence of effective treatment methods for Duchenne muscular dystrophy (DMD)
calls for new therapeutic approaches. One of the promising treatment methods for DMD is stem
cell therapy. This study demonstrates the impact of fetal stem cells (FSCs) on functional capacity
and life quality of DMD patients and the ability of FSCs to prevent DMD-related complications
in order to inhibit the disease progression. FSC therapy substantially improves functional
capacity, life quality, left ventricular ejection fraction, and forced vital capacity of the lungs of
DMD patients; this was confirmed by comparison of neurological, laboratory (aspartate aminotransferase,
alanine aminotransferase, creatine phosphokinase, and lactate dehydrogenase), and
morphofunctional findings (left ventricular ejection fraction and forced vital capacity) in DMD
patients before the treatment, and 6 and 12 months after the FSC treatment.
READ MORE: DOVE PRESS
- Sunday, 19 July 2015 19:51
“We don’t use the word ‘fetal’ too much”
Maynard Howe CEO, Stemedica Cell Technologies of San Diego
TIJUANA, Mexico — John Brodie decided he had nothing to lose. So did Gordie Howe, who was losing his will to live.
After each suffered massive strokes, both sports heroes barely could walk, talk or take care of themselves.
“He was definitely close to giving up hope,” said Howe’s son, Murray.
So they tried something new. They left the United States to receive experimental treatments that included stem cell injections derived from the brain tissue of a single aborted human fetus.
Both men now can walk, exercise and communicate better, seemingly sparked back to life after reaching the precipice of death.
READ MORE: USA TODAY